Avidity Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Avidity Biosciences LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11328
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avidity Biosciences LLC (Avidity Biosciences), formerly Avidity NanoMedicines LLC is a biotech company that develops antibody oligonucleotide conjugates (AOCs). The company’s proprietary platform technology has enhanced pharmacokinetic and biodistribution properties that improves the delivery of multiple therapeutic oligonucleotides. Its pipeline of therapeutic programs are intended for the treatment of rare muscle disorders and other serious diseases, including Duchenne muscular dystrophy, myotonic dystrophy and muscle atrophy. The company has research collaborations with leading pharma companies, to discover antibody-based drug candidates against various therapeutic targets. Avidity Biosciences is headquartered in San Diego, California, the US.

Avidity Biosciences LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avidity Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avidity Biosciences LLC, Medical Devices Deals, 2012 to YTD 2018 9
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Avidity Biosciences Raises USD10 Million in Series B Venture Financing 11
Avidity NanoMedicines Raises USD6 Million in Series B Venture Financing 13
Avidity NanoMedicines Raises US$9 Million In Series A Financing 14
Partnerships 15
Sevion Therapeutics Enters into Research Agreement with Avidity NanoMedicines 15
Equity Offering 16
Avidity Biosciences Raises Funds through Private Placement of Equity Financing 16
Avidity Biosciences LLC – Key Competitors 17
Avidity Biosciences LLC – Key Employees 18
Avidity Biosciences LLC – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Key Facts 2
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avidity Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avidity Biosciences LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Avidity Biosciences LLC, Medical Devices Deals, 2012 to YTD 2018 9
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Avidity Biosciences Raises USD10 Million in Series B Venture Financing 11
Avidity NanoMedicines Raises USD6 Million in Series B Venture Financing 13
Avidity NanoMedicines Raises US$9 Million In Series A Financing 14
Sevion Therapeutics Enters into Research Agreement with Avidity NanoMedicines 15
Avidity Biosciences Raises Funds through Private Placement of Equity Financing 16
Avidity Biosciences LLC, Key Competitors 17
Avidity Biosciences LLC, Key Employees 18

List of Figures
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avidity Biosciences LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Avidity Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avanza Bank Holding AB:企業の戦略・SWOT・財務分析
    Avanza Bank Holding AB - Strategy, SWOT and Corporate Finance Report Summary Avanza Bank Holding AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Trina Solar Co Ltd:企業の戦略的SWOT分析
    Trina Solar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Information Analysis Inc (IAIC):企業の財務・戦略的SWOT分析
    Summary Information Analysis Inc (IAI) is a technology company that offers technical solutions. The company offers IT services such as legacy mainframe modernization, database conversion and migration, electronic forms conversion, ebusiness and web based solutions, integrated tablet and mobile appli …
  • Aviva Poland:企業の戦略・SWOT・財務情報
    Aviva Poland - Strategy, SWOT and Corporate Finance Report Summary Aviva Poland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Banque Cramer & Cie SA:企業の戦略・SWOT・財務情報
    Banque Cramer & Cie SA - Strategy, SWOT and Corporate Finance Report Summary Banque Cramer & Cie SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aldevron LLC-製薬・医療分野:企業M&A・提携分析
    Summary Aldevron LLC (Aldevron) is a custom manufacturing and development service provider. The company manufactures plasmid deoxyribonucleic acid for research, preclinical and clinical applications. It offers nucleic acid, protein, and antibody services. Aldevron's protein production services inclu …
  • BHG SA – Brazil Hospitality Group:企業の戦略・SWOT・財務分析
    BHG SA - Brazil Hospitality Group - Strategy, SWOT and Corporate Finance Report Summary BHG SA - Brazil Hospitality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Intercept Energy Services Inc (IES):石油・ガス:M&Aディール及び事業提携情報
    Summary Intercept Energy Services Inc (Intercept Energy), formerly Global Green Matrix Corp is an oilfield service firm that offers water heating services. The firm provides services such as oilfield services, energy extraction and related services, frac water heating, oil sands processing, and oilf …
  • BAE Systems Australia:企業の戦略・SWOT・財務情報
    BAE Systems Australia - Strategy, SWOT and Corporate Finance Report Summary BAE Systems Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hey-Song Corporation:戦略・SWOT・企業財務分析
    Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report Summary Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Yissum Research Development Company of the Hebrew University of Jerusalem Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC), a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketing and licensing the inventions, products, and technologies developed by the university's faculty, …
  • Nagacorp Ltd:企業の戦略・SWOT・財務情報
    Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report Summary Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Copelouzos group-エネルギー分野:企業M&A・提携分析
    Summary Copelouzos group (Copelouzos) is an energy company that offers business development services. The company’s services include energy production and training, equipment supply, wastes management, natural gas, and concession and property services. It’s waste management services include residues …
  • Zavante Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops novel therapies for the treatment of infectious diseases such as due to multi-drug resistant (MDR) bacteria. The company offers drugs for the treatment of diseases …
  • Zara Investment (Holding) Co Ltd:企業の戦略・SWOT・財務情報
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Samsung SDS Co Ltd (018260):企業の財務・戦略的SWOT分析
    Samsung SDS Co Ltd (018260) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • OpenHydro Group Limited-エネルギー分野:企業M&A・提携分析
    Summary OpenHydro Group Limited (OpenHydro), a subsidiary of DCNS S.A. designs and manufactures marine turbines for generating renewable energy from tidal streams. The company offers installation and maintenance services for the construction of tidal farms using its Open-Centre Turbine technology. T …
  • Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析
    Summary Nanobiotix SA (Nanobiotix) is a late stage clinical company which develops nanomedicines for the treatment of cancers. The company develops first-in-class products utilizing its proprietary technology NanoXray, based on the physical mode of action of nanoparticles that increase the X-rays do …
  • Kurita Water Industries Ltd:企業の戦略・SWOT・財務情報
    Kurita Water Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Kurita Water Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Iridex Corp (IRIX):企業の財務・戦略的SWOT分析
    Summary Iridex Corp (Iridex) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glaucoma device …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆